Kimberly-Clark Reports Q3 2026 Results Amid China Social Media Disruptions
Kimberly-Clark (KMB) reported third-quarter 2026 results characterized by a mixed performance. While adjusted EPS rose 17.2% year-over-year to $1.70 due to lower interest expenses and tax benefits, net sales fell slightly by 0.4% to $4.1 billion. The company faced significant headwinds in China, where false social media allegations regarding product safety caused a 530 basis point hit to adjusted operating profit and drove organic sales down. Despite these international challenges, North American performance remained resilient with organic sales up 0.4%, supported by strong e-commerce growth exceeding 20% and market share gains in the tissue segment. However, margins were pressured by a 130 basis point decline to 35.5%, driven by cost inflation and rising North American spot freight rates. Management noted that rebuilding consumer trust in China will be a multi-year endeavor.